Opioid Early Career Scholar Program
An intensive multi-day opioid REMS initiative in Pain Management
Register Today
Early Bird Deadline: February 14th
March 15-16, 2025
Wyndham Garden Lake Buena Vista
Buena Vista, FL
@cmeoutfitters#health#wellness
Keeping these young investigators engaged & supported in their important work gives patients continued hope for a better tomorrow. Our future depends on progress. We are thankful for these mentors and this platform! @EGFRSummit#ResearchMatters#anyonewithlungs
Immuno-oncology Young Investigators! Join us LIVE online or in-person at #SITC22 Nov 11th at 6:00pm ET & earn 1.0 CME Credit!
Our faculty panel will discuss the power of immunotherapy in HCC & BTC!
Register for in-person/online here ➡️ https://t.co/cKuVN369uX
Extremely grateful @BWFUND for the support!!! Also thankful for the amazing mentorship, it really makes a difference. Also congrats to all the fellow awardees!
Honored to be included as an ASCO YIA recipient this year for my work on systemic inflammation in people experiencing #lymphedema following breast cancer tx!
Also so happy to be sharing this experience with @OSUCCC_James co-fellows @JasmineSukumar & Nate Denlinger!
Deeply honored to have been nominated and selected for 2022 class of #40 under #40 in Oncology 🙂 @StephensonCC@OUHealth@sitcancerECS
Join us for the reception and ceremony on June 4 #ASCO22 😊
Thank you #AACR2022 for an incredible week of science, friends and food. You even brought #Tcells and #macrophages together.
Heard among friends in this photo: “it’s not all about the Tcell”. @JimAllisonPhD @MiriamMerad @PamSharmaMDPhD
So excited to see FDA approval of the first anti-LAG3, in combination with anti-PD1! It has been a long road but we have had the pleasure of working with an amazing team of trainees and collaborators dissecting LAG3 function since ~2020 (20+ papers)! 1/2 https://t.co/bOiY4GaCHG
Out in @NEJM this week, our perspective on some recent outstanding work defining the phenotype of tumor-infiltrating T cells across cancer types, and our thoughts on next steps.
Tumor-Infiltrating T Cells — A Portrait | NEJM https://t.co/WoAI49kbFT
@YaleCancer@YaleMed
We would like to extend a THANK YOU to Rosemary Ostmann from @rosecomm & @ivybelkins from @EGFRResisters for sharing all of their insights on best practices to becoming a digital opinion leader during last Friday’s webinar. 💻🔎
See a few of the topics below! #DOL#MedTwitter
Our webinar on best practices to becoming a digital opinion leader is this Fri 1/21 @ 12p!
Reply to this tweet w/ your Q's on best practices as a trusted source & hear from communications expert @rosecomm answer your Q's.
Click ⬇️ & reserve your spot!
https://t.co/iVuwKO53uV
Hey YIF Alums!
What are you most curious about in becoming a trusted source for science in the age of digital media? 🤔Join us on Fri 1/21 @ 12p to see how you can increase the reach of your research.🌐
Click ⬇️to register for this can’t miss session!
https://t.co/iVuwKOmEmt